Around 54 million to 60 million people throughout the world are annually surviving with Traumatic Brain Injury annually. CT scan tests of the head are the common diagnostic choices in such cases. This extensive use of CT scans leads to unnecessary radiation exposure with high costs.
Lawson Health Research Institute, Memorial Sloan Kettering Cancer Center, the Royal Marsden and Epic Sciences conducted an international mutual study which discovered a novel blood test that can foresee advanced prostate cancer patient response to particular treatments, resulting in better survival.
Glaucoma is an eye disorder causing irreversible blindness and affects around 60 million people throughout the world. This condition leads to the loss of retinal ganglion cells, located near the surface of the retina. The prime focus of glaucoma research is to put an end to the loss of these cells in the initial stages.
The research team from Stanford University have invented a novel wearable that could measure the level of a patient’s cortisol from their sweat. Cortisol is a hormone linked to stress, which takes several days to test. This scientific discovery was recently published in Science Advances.
The first-ever 3D, color X-rays were tested on a human by New Zealand Scientists, using technology that promises to enhance medical diagnostics in oncology, cardiology, neurology and orthopedics.
One of the largest clinical laboratories in the U.S, LabCorp Diagnostics of North Carolina faced a security breach by hackers forcing it to shut down on Sunday to combat the cyber attack.
Viral hepatitis is a major global health issue since it is the seventh leading cause of death worldwide. Around half of hepatitis-related deaths reported are due to the hepatitis B virus infection, which is transmitted through blood and body fluids.
Hepatitis B virus (HBV) causes liver disease that leads to one million deaths throughout the world every year. Extensive research is going on to find the most effective, quick and accurate diagnostic measures followed by therapeutic solutions.
The research team claimed that the effectiveness of drugs depends on the time of administration on a personalized level. Their goal was to identify the biomarkers in blood to characterize the ‘internal time’ of an individual.
Using nanotechnology, the research team developed tiny platinum nanomotors to target Zika and microbeads to bind the virus. When they are added to a sample containing Zika, a 3D complex is formed which moves in the presence of hydrogen peroxide. This unique motion signal can be perceived using a smartphone by attaching it to a cost-effective optical device. The 3D Zika complex moves rapidly compared to the slower movement of other non-target viruses.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.